Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban vs Enoxaparin for VTE Prevention after Total Knee Arthroplasty
NCT01181102Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2009
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of edoxaban in venous thromboembolism (VTE), sponsored by Daiichi Sankyo Co., Ltd.. Started Mar 2009; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01181102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181102.